WallStreetZen

NYSE: JNJ
Johnson & Johnson Earnings & Revenue

JNJ past earnings growth

How has JNJ's earnings growth performed historically?
Company
16.61%
Industry
22.33%
Market
96.23%
JNJ's earnings have grown slower (4.3% per year) than the US Drug Manufacturers - General industry average (11.67%)
Performance
JNJ's earnings have grown slower (4.3% per year) than the US market average (33.21%)
Performance
JNJ's earnings growth is accelerating - its growth over the last year (16.61%) is above its 5-year compound annual rate (4.3%)
Performance

JNJ past revenue growth

How has JNJ's revenue growth performed historically?
Company
10.79%
Industry
18.11%
Market
42.59%
JNJ's revenue has grown slower (4.7% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
JNJ's revenue has grown slower (4.7% per year) than the US market average (19.59%)
Performance
JNJ's revenue growth is accelerating - its growth over the last year (10.79%) is above its 5-year compound annual rate (4.7%)
Performance

JNJ earnings and revenue history

Current Revenue
$89.2B
Current Earnings
$17.8B
Current Profit Margin
19.9%
JNJ's has not demonstrated consistent long-term earnings growth over the past 10 years (58.96%)
Performance

JNJ Return on equity

Current Company
27%
Current Industry
33.2%
Current Market
23.1%
JNJ's Return on Equity (27%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

JNJ Return on assets

Current Company
10.2%
Current Industry
7.3%
JNJ is generating higher Return on Assets (10.2%) than the US Drug Manufacturers - General industry average (7.57%)
Performance

JNJ Return on capital employed

Current Company
14.79%
Current Industry
11.7%
JNJ has gotten more efficient at generating Return on Capital (14.79%) compared to 3 years ago (14.72%)
Performance

Johnson & Johnson Earnings & Revenue FAQ

What were JNJ's earnings last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q2 2021 earnings per share (EPS) of $2.38, up 72.46% year over year. Total Johnson & Johnson earnings for the quarter were $6.28 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $1.38.

What was JNJ's earnings growth in the past year?

As of Q4 2021, Johnson & Johnson's earnings has grown 16.61% year over year. This is 5.72 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 22.33%. Johnson & Johnson's earnings in the past year totalled $17.77 billion.

What was JNJ's revenue last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q2 2021 revenue of $23.31 billion up 27.14% year over year. In the same quarter last year, Johnson & Johnson's revenue was $18.34 billion.

What was JNJ's revenue growth in the past year?

As of Q4 2021, Johnson & Johnson's revenue has grown 10.79% year over year. This is 7.31 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 18.11%. Johnson & Johnson's revenue in the past year totalled $89.19 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.